[by date] [by subject] [by continent]

CONGESTIVE HEART FAILURE: New Therapeutic Approaches

Cambridge Healthtech Institute , San Diego, California
February 2-3,1998

Congestive heart failure (CHF), one of the leading manifestations of
cardiovascular disease, continues to be a major cause of morbidity and
mortality. The incidence of CHF can only be expected to increase as a
result of the aging of the population. Therapeutic advances based on new
beta-blockers and dual activity ACE inhibitors, endothelin antagonists, and
drugs targeting other novel mechanisms will be presented. Diagnostics and
new methods for evaluating the effectiveness of pharmaceuticals are being
developed for this indication.

Registration :
Cambridge Healthtech Institute
1037 Chestnut Street, Newton Upper Falls, MA 02164
Tel: 617-630-1300 Fax: 617-630-1325
E-Mail: chi@healthtech.com

Deadline for Abstracts: Dec. 12, 1997

Email for Requests and Registration: chi@healthtech.com

Posted by: James Larkin Host: date: September 19, 97 12:27:10
Generated by meetings and positions 1.0 by Kai Garlipp